News
AbbVie’s history stems from the late 19th-century work of Chicago physician Wallace Calvin Abbott, whose small operation of ...
Big bank earnings, June CPI inflation data, and U.S. retail sales, along with updates from TSMC, Netflix and Johnson & ...
A new law establishes the Texas Quantum Initiative to provide funds and boost investment in quantum computing research, ...
Broader macroeconomic uncertainty has resulted in continued cautiousness for both investors and acquirers in the in vitro ...
Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.
Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...
Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 81% ownership. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results